Bare-metal Stents Market by Product, End Users

List of Tables

[184 Pages Report] The Bare-metal Stents Market size was estimated at USD 6.23 billion in 2023 and expected to reach USD 6.57 billion in 2024, at a CAGR 5.66% to reach USD 9.17 billion by 2030.

A bare-metal stent is a small, mesh-like metal tube used in medical procedures to support and keep open a blocked artery. This type of stent is often used during a procedure called angioplasty to treat arteries that have been narrowed and blocked due to coronary artery disease. The stent helps restore blood flow and prevents the artery from narrowing. Unlike drug-eluting stents, bare-metal stents do not have a coating that releases medication into the artery; they are simply made of metal materials. The rising prevalence of cardiovascular conditions, such as coronary artery diseases, across the globe acts as a primary driver for the demand for bare-metal stents. As these diseases remain among the leading causes of death worldwide, the need for effective, minimally invasive solutions such as stenting is crucial and continues to grow. However, bare-metal stents have faced significant challenges due to product recalls. Such recalls often stem from issues related to device malfunctions or safety concerns that could potentially harm patients. Moreover, the improvements in manufacturing technologies for bare-metal stents have allowed for more precise and reliable products. With techniques such as laser cutting and improved biocompatible materials, these stents are increasingly effective in resisting corrosion and ensuring better patient outcomes.

KEY MARKET STATISTICS
Base Year [2023]	USD 6.23 billion
Estimated Year [2024]	USD 6.57 billion
Forecast Year [2030]	USD 9.17 billion
CAGR (%)	5.66%

Regional Insights

In the Americas, the United States and Canada are significant players in the bare-metal stents market, reflecting a mature healthcare system and high incidence rates of cardiovascular diseases. Consumers in the Americas are inclined towards minimally invasive procedures, driving demand for stents. Recent investments have focused on technological advancements and reducing the risk of restenosis. Market penetration is high, and the focus is on quality and brand reputation, influencing purchasing behaviors. On the other hand, the EMEA market is diverse, with regulatory rigor playing a critical role in shaping the market. Recent EU Medical Device Regulations have impacted stenting practices, with a strong emphasis on safety and efficacy. Consumer trust is highly dependent on regulatory approvals, and a steady demand is aligned with healthcare provisions. Moreover, the Asia Pacific region has a large and aging population, which increases the prevalence of cardiovascular diseases and, thus, the demand for interventions involving bare-metal stents. Countries such as China and India, with their vast populations, are seeing higher numbers of coronary artery cases due to shifts towards urban lifestyles and increased occurrences of risk factors such as hypertension, diabetes, and obesity.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Bare-metal Stents Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers
- Rising incidences of cardiovascular diseases (CVDs) globally
- Increasing preference for minimally invasive procedures

Market Restraints
- Availability of alternative treatment in the market

Market Opportunities
- Ongoing advancements in stent design, materials, and manufacturing processes
- Rising healthcare expenditure, coupled with expanding access to medical services and technologies

Market Challenges
- Difficulties and complications with stent implantation

Market Segmentation Analysis
- Product: Utilization of balloon catheter and metallic stent in cardiac and peripheral vascular medical procedures
- End Users: Increasing usage of bare-metal stents in hospitals for emergency interventions and post-operative recovery

Market Disruption Analysis
Porter's Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Bare-metal Stents Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Bare-metal Stents Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

FDA Approves Boston Scientific's AGENT Drug-Coated Balloon, Enhancing Peripheral Artery Disease Treatments

Boston Scientific has received FDA approval for its AGENT Drug-Coated Balloon, a pivotal development in treating peripheral artery disease (PAD). This new medical device is designed to maintain arterial openness and prevent re-blockage, addressing a common issue in PAD therapies. The approval is based on positive outcomes from clinical trials that demonstrated significant improvements in patient conditions with minimal risks. This development marks a significant milestone in vascular medicine, promising enhanced treatment solutions for patients suffering from arterial diseases. [Published On: 2024-03-01]

Kaneka Corporation Enhances Stent Development Capabilities with Acquisition of JMDT

Kaneka Corporation enhanced its position in the medical device sector by acquiring all shares of Japan Medical Device Technology Co., Ltd. (JMDT), a prominent developer and manufacturer of medical devices located in Kamimashiki-gun, Kumamoto. This strategic acquisition positions Kaneka as a fully integrated company in the endovascular catheter market, particularly focusing on coronary artery disease treatments through stenting, a segment worth 30 billion yen in Japan. [Published On: 2023-11-30]

FDA Greenlights Medinol's Innovative Drug-Eluting Coronary Stent

The U.S. Food and Drug Administration (FDA) has officially approved the use of Medinol's latest drug-eluting stent in coronary artery interventions. This state-of-the-art stent integrates medication that actively prevents artery re-blockage, a common issue post-surgery. Key features of the stent include its enhanced design, which significantly betters its flexibility and positioning accuracy compared to traditional bare-metal stents. This approval marks a significant milestone in coronary treatment options, offering enhanced effectiveness and safety, thereby improving patient outcomes in managing coronary artery disease. [Published On: 2023-10-24]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Bare-metal Stents Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Bare-metal Stents Market, highlighting leading vendors and their innovative profiles. These include Abott Laboratories, ACE CARDIOPATHY, B. Braun SE, Becton, Dickinson and Company, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Cook Group Incorporated, Medtronic PLC, MeKo Manufacturing e.K., Meril Life Sciences Pvt Ltd., MicroPort Scientific Corporation, Relisys Medical Devices Limited, SLTL Group, STENTYS SA, Stryker Corporation, Terumo Corporation, and Translumina Therapeutics.

Market Segmentation & Coverage

This research report categorizes the Bare-metal Stents Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Balloon Catheter
- Balloon Expendable Stent
- Metallic Stent
- Self-Expendable

End Users
- Ambulatory Surgical Centers
- Cardiac Catheterization Laboratories
- Hospitals

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

Product Code: MRR-CD5A9334DAB9

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising incidences of cardiovascular diseases (CVDs) globally
  - 5.1.1.2. Increasing preference for minimally invasive procedures
- 5.1.2. Restraints
  - 5.1.2.1. Availability of alternative treatment in the market
- 5.1.3. Opportunities
  - 5.1.3.1. Ongoing advancements in stent design, materials, and manufacturing processes
  - 5.1.3.2. Rising healthcare expenditure, coupled with expanding access to medical services and technologies
- 5.1.4. Challenges
  - 5.1.4.1. Difficulties and complications with stent implantation
5.2. Market Segmentation Analysis
- 5.2.1. Product: Utilization of balloon catheter and metallic stent in cardiac and peripheral vascular medical procedures
- 5.2.2. End Users: Increasing usage of bare-metal stents in hospitals for emergency interventions and post-operative recovery
5.3. Market Disruption Analysis
5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Bare-metal Stents Market, by Product

6.1. Introduction
6.2. Balloon Catheter
6.3. Balloon Expendable Stent
6.4. Metallic Stent
6.5. Self-Expendable

7. Bare-metal Stents Market, by End Users

7.1. Introduction
7.2. Ambulatory Surgical Centers
7.3. Cardiac Catheterization Laboratories
7.4. Hospitals

8. Americas Bare-metal Stents Market

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Bare-metal Stents Market

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Bare-metal Stents Market

10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape

11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
- 11.3.1. FDA Approves Boston Scientific's AGENT Drug-Coated Balloon, Enhancing Peripheral Artery Disease Treatments
- 11.3.2. Kaneka Corporation Enhances Stent Development Capabilities with Acquisition of JMDT
- 11.3.3. FDA Greenlights Medinol's Innovative Drug-Eluting Coronary Stent
11.4. Strategy Analysis & Recommendation

12. Competitive Portfolio

12.1. Key Company Profiles
12.2. Key Product Portfolio